碳离子辐射治疗后长期瘤控制促进局部先进的宫清细胞腺癌
Amelia Barcellini1,2, Alessandro Vai3, Eloisa Arbustini4
1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
International journal of particle therapy
|September 22, 2025
概括
这项案例研究强调了碳离子辐射疗法作为对罕见的,抗常规治疗的侵袭性宫癌的潜在治疗方法. 混合光束方法在实现持久的局部控制和潜在增强全身免疫反应方面表现有希望.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 遗传学 是一个遗传学.
背景情况:
- 子宫的透明细胞腺癌是一种罕见的,攻击性的癌症亚型.
- 它通常对传统的辐射疗法具有抗性,并且缺乏特定的治疗指南.
- ATAXIA telangiectasia突变可以影响癌症治疗结果.
研究的目的:
- 报告一个患有无氧性 telangiectasia 突变的患者的子宫部局部发达的清晰细胞腺癌病例.
- 为了评估碳离子辐射疗法的疗效和耐受性,在化学辐射疗法后,在不适合支臂治疗的患者中增加放射疗法.
- 探索遗传背景在治疗反应和全身免疫效应中的潜在作用.
主要方法:
- 患者接受了标准化疗和放射治疗,随后进行了碳离子辐射疗法.
- 采用了混合光束辐射策略.
- 评估了临床反应,局部控制和节点反应.
主要成果:
- 混合光束策略被患者容忍得很好.
- 取得了持久的局部控制.
- 观察到一个显著的节点反应,表明可能的abscopal效应.
结论:
- 碳离子辐射疗法可能是克服宫癌中放射电阻的可行选择.
- 患者的遗传背景 (ataxia telangiectasia突变) 可能在调解系统性免疫效应方面发挥作用.
- 需要进一步的研究来探索碳离子疗法的潜力及其与宫癌治疗中的遗传因素的相互作用.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


